POZN

Pozen, Inc. News Headlines

$7.86
*  
0.07
0.9%
Get POZN Alerts
*Delayed - data as of Dec. 24, 2014  -  Find a broker to begin trading POZN now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Ohr Pharmaceutical (OHRP) Soars: Stock Adds 16.9% in Session - Tale of the Tape
6/24/2014 8:18:00 AM - Zacks.com


Aerie Pharmaceuticals (AERI) in Focus: Stock Moves 6.8% Higher - Tale of the Tape
6/20/2014 8:18:00 AM - Zacks.com


AcelRx Pharmaceuticals (ACRX) Jumps: Stock Rises 9.0% - Tale of the Tape
6/17/2014 8:18:00 AM - Zacks.com


Alcobra Ltd. (ADHD) Jumps: Stock Rises 8.7% - Tale of the Tape
6/12/2014 8:18:00 AM - Zacks.com


BioCryst Pharmaceuticals (BCRX) Soars: Stock Adds 10.9% in Session - Tale of the Tape
5/28/2014 8:18:00 AM - Zacks.com


Orexigen Will Run: Here's Why
5/27/2014 3:47:00 PM - Seeking Alpha


Weekly Insider Sells Highlight: AR, CSCO, SUTR, POZN, JAH
5/27/2014 12:04:50 PM - GuruFocus


Avanir Pharmaceuticals (AVNR) in Focus: Stock Moves 6.1% Higher - Tale of the Tape
5/15/2014 8:18:00 AM - Zacks.com


Pozen, Inc.: Buy This Biotech For Growth And Income
5/10/2014 9:13:00 AM - Seeking Alpha


Pozen Is Overvalued, More So Now After Recent FDA Rejection - Here Is Why
4/28/2014 11:57:00 AM - Seeking Alpha


Pre-Market Most Active for Apr 28, 2014 : AZN, BAC, PFE, HSBC, FB, NEM, UN, ERIC, FURX, POZN, BLDP, QQQ
4/28/2014 7:38:53 AM - NASDAQ.com News


Sector Update: Healthcare Stocks Higher Pre-Market; Pozen Rises on Q4 Results
3/5/2014 8:31:56 AM - MT Newswires


Sector Update: Healthcare
3/5/2014 8:31:36 AM - MT Newswires


Synthetic Biologics Under The Radar With Upcoming Multiple Sclerosis Data Catalyst
2/19/2014 7:55:00 AM - Seeking Alpha


Notes From One-On-One Meetings During San Fran Biotech Week - Day 2
1/23/2014 9:05:00 AM - Seeking Alpha


Jason Napodano Positions For 2014: Biotech M&A Growth Trend To Continue
12/31/2013 10:45:00 AM - Seeking Alpha


Pozen, Inc. (POZN) Ex-Dividend Date Scheduled for December 31, 2013
12/30/2013 9:00:02 AM - NASDAQ.com News


Sector Update: Healthcare Stocks Mixed Pre-Market; TSRO Sinks 7% on Phase 3 Results of Rolapitant
12/23/2013 8:19:09 AM - MT Newswires


Sector Update: Healthcare
12/23/2013 8:15:36 AM - MT Newswires


The Market Is Missing Pozen's Potential Cash Distribution And Upcoming Approval
11/7/2013 8:17:45 AM - SeekingAlpha


POZEN Inc. (POZN) Shares March Higher, Can It Continue? - Tale of the Tape
10/25/2013 9:07:56 AM - Zacks.com


POZEN Inc. And Chelsea Therapeutics Primed For Big Gains On The Road To PDUFA
10/23/2013 2:51:00 PM - Seeking Alpha


Pozen Seeks Partner For Safer Aspirin By Year-End
8/7/2013 12:02:00 PM - Seeking Alpha


FDA Decisions: Interesting Biotechnology Catalyst Events
7/9/2013 11:04:00 AM - Seeking Alpha


A Deal For Pozen's PA Could Send Shares Soaring
3/6/2013 1:48:00 PM - Seeking Alpha